86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review
86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is a paper indexed in ScholarIQ from OpenAlex.
How many citations does 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review have?
86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has 0 citations in the OpenAlex counts ScholarIQ stores.
When was 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review published?
86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has 2025 year in the ScholarIQ index.
What is the open-access status of 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?
86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review has closed oa status in the ScholarIQ index.
What is the DOI of 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?
The DOI for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is on the source record.
What is the OpenAlex record for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review?
The OpenAlex for 86: Comparing Ritlecitinib Efficacy and Safety to other JAK-inhibitors for Alopecia Areata Treatment in Pediatric Population: A Systematic Review is on the source record.